ScreenerHero

SBC SBC Medical Group Holdings Incorporated - Common Stock

NAS · US · Healthcare · Consulting Services · sbc-holdings.com
5.280USD+3.73%Mkt Cap: 523.49M $P/E: 10.60

SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and …

Industry Peers

Consulting Services
Screen all
EXPN
Experian plc
$23.54BUSDP/E 20.2
SGSN
SGS SA
$21.22BUSDP/E 27.6
VRSK
Verisk Analytics, Inc. - Common Stock
$21.47BUSDP/E 25.1
EFX
Equifax, Inc. Common Stock
$16.45BUSDP/E 24.6
BVI
Bureau Veritas SA
$12.70BUSDP/E 23.3
BAH
Booz Allen Hamilton Holding Corporation Common Stock
$8.10BUSDP/E 10.6
DKSH
DKSH Holding AG
$5.11BUSDP/E 21.1
FCN
FTI Consulting, Inc. Common Stock
$3.77BUSDP/E 16.5
HURN
Huron Consulting Group Inc. - Common Stock
$2.58BUSDP/E 24.4
IPS
Ipsos SA
$1.58BUSDP/E 8.8
ICFI
ICF International, Inc. - Common Stock
$1.47BUSDP/E 16.9
CRAI
CRA International,Inc. - Common Stock
$1.07BUSDP/E 22.7
ROMA
Roma Green Finance Limited - Class A Ordinary Shares
$512.26MUSD
DATA
GlobalData Plc
$424.88MUSDP/E 11.9
ENENTO
Enento Group Oyj
$378.29MUSDP/E 26.7
YOU
YouGov plc
$332.89MUSDP/E 26.1
PPHC
Public Policy Holding Company, Inc. - Common Stock
$318.48MUSD
REJL-B
Rejlers AB (publ)
$300.12MUSDP/E 18.3
EFTY
Etoiles Capital Group Co., Ltd. - Class A Ordinary Shares
$302.05MUSDP/E 187.8
ELIX
Elixirr International plc
$278.49MUSDP/E 13.1

Key Statistics

Company
Market Cap523.49M USD
Enterprise Value403.18M USD
Revenue (TTM)175.17M USD
Gross Profit127.28M USD
Net Income (TTM)50.99M USD
Revenue/Share1.71 USD
Last Price5.280 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees863
CountryUS
SectorHealthcare
IndustryConsulting Services
ISIN—
Valuation
P/E (Trailing)10.60
P/E (Forward)9.43
PEG1.95
EV/EBITDA5.87
EV/Revenue2.30
P/S2.99
P/B1.98
EPS (TTM)0.47
EPS (Forward)0.54
52W Range
2.780100% of range5.220
52W High5.220 USD
52W Low2.780 USD
Profitability
Gross Margin73.32%
Oper. Margin38.55%
EBITDA Margin39.18%
Profit Margin29.37%
ROE20.54%
ROA13.40%
Growth
Revenue Growth13.40%
Earnings Growth338.90%
Cash Flow & Leverage
Operating CF24.67M USD
CapEx (TTM)2.70M USD
FCF Margin36.08%
FCF Yield12.07%
Net Debt-136.39M USD
Net Debt/EBITDA-1.99
Balance Sheet
Debt/Equity0.21
Current Ratio3.31
Quick Ratio3.19
Book Value/Sh2.57 USD
Cash/Share1.79 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.750 USD
Upside (mean)+65.7%
Target Range7.000 USD – 11.00 USD
7.000+65.7% to mean11.00
# Analysts4
Ownership
Shares Out.102.85M
Float18.11M
Insiders81.53%
Institutions4.41%
Short Interest
Short Ratio3.7d
Short % Float3.78%
Short % Out.0.70%
Shares Short717.53K
Short (prev mo.)674.55K
Technical
SMA 504.021 (+31.3%)
SMA 2003.812 (+38.5%)
Beta0.63
S&P 52W Chg14.58%
Avg Vol (30d)216.01K
Avg Vol (10d)215.86K
Technical Indicators
RSI (14)70.4
MACD0.3493
MACD Signal0.3510
MACD Hist.-0.0017
BB Upper5.288 USD
BB Middle4.641 USD
BB Lower3.995 USD
BB Width27.85%
ATR (14)0.2352 USD
Vol Ratio (20d)0.82x